Vaccinex, Inc. to Present at CHDI’s 17th Annual HD Therapeutics Conference Meeting
24 févr. 2022 08h00 HE
|
Vaccinex, Inc.
ROCHESTER, N.Y., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative...